Sera Prognostics was founded to develop diagnostic tests for the early prediction of a womans individualized risk of premature birth, preeclampsia, and other pregnancy complications. Seras tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans.
| Website | http://www.seraprognostics.com |
| Ticker | SERA |
| Revenue | $31 million |
| Employees | View employees |
| Founded | 2008 |
| Address | 2749 E Parleys Way Ste 200, Salt Lake City, Utah 84109, US |
| Phone | +1 801-990-0520 |
| Technologies |
JavaScript
,
HTML
,
PHP
+33 more
(view full list)
|
| Industry | Medical Testing & Clinical Laboratories, Biotechnology, Healthcare, Science and Engineering, Health Care, Hospital, Medical, Medical Device |
| Competitors | Roche, Thermo Fisher Scientific, Merck & Co., Inc., Quest Diagnostics, Hologic, Inc., Illumina, Natera, Myriad Genetics, Invitae, Genomic Health +36 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 6215 Companies |
Looking for a particular Sera Prognostics employee's phone or email?
Sera Prognostics Questions
The Sera Prognostics annual revenue was $31 million in 2026.
Sera Prognostics is based in Salt Lake City, Utah.
The NAICS codes for Sera Prognostics are [621, 62, 62151, 6215].
The SIC codes for Sera Prognostics are [80, 807].
